Elevance Health Reports Q2 2026 Earnings and Provides Updated Guidance
Elevance Health (ELV) reported adjusted diluted EPS of $7.45 for the second quarter, exceeding internal projections due to strong performance across segments. The company raised its full-year adjusted EPS guidance to at least $27 from a re-established baseline of $26 and set a 2027 earnings target of at least 12% growth.
Topics: financial performance guidance healthcare